Author: Facts and Comparisons (Firm)
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574390735
Category : Drugs
Languages : en
Pages : 2332
Book Description
This authoritative annual compilation includes more than 2,000 prescription drugs, and almost 6,000 over-the-counter items, all grouped by therapeutic category for ease of reference. It has more than 3,000 charts and tables, and a 48-page full-color section illustrating the most frequently prescribed capsules and tablets. It covers orphan drugs, as well as manufacturers, distributors and Canadian trade names.
Drug Facts and Comparisons
Author: Facts and Comparisons (Firm)
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574390735
Category : Drugs
Languages : en
Pages : 2332
Book Description
This authoritative annual compilation includes more than 2,000 prescription drugs, and almost 6,000 over-the-counter items, all grouped by therapeutic category for ease of reference. It has more than 3,000 charts and tables, and a 48-page full-color section illustrating the most frequently prescribed capsules and tablets. It covers orphan drugs, as well as manufacturers, distributors and Canadian trade names.
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574390735
Category : Drugs
Languages : en
Pages : 2332
Book Description
This authoritative annual compilation includes more than 2,000 prescription drugs, and almost 6,000 over-the-counter items, all grouped by therapeutic category for ease of reference. It has more than 3,000 charts and tables, and a 48-page full-color section illustrating the most frequently prescribed capsules and tablets. It covers orphan drugs, as well as manufacturers, distributors and Canadian trade names.
A to Z Drug Facts
Author: David S. Tatro
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574390629
Category : Chemotherapy
Languages : en
Pages : 0
Book Description
Alphabetically organized, this drug reference integrates successful drug therapy and patient care. Monographs are divided into pharmacological and patient care considerations, and include indications, dosages, and side effects. Includes up-to-date information on more than 4,500 new and orphan drugs. Side effects are organized by body system. 839 illustrations.
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574390629
Category : Chemotherapy
Languages : en
Pages : 0
Book Description
Alphabetically organized, this drug reference integrates successful drug therapy and patient care. Monographs are divided into pharmacological and patient care considerations, and include indications, dosages, and side effects. Includes up-to-date information on more than 4,500 new and orphan drugs. Side effects are organized by body system. 839 illustrations.
A to Z Drug Facts
Author: David S. Tatro
Publisher: Facts and Comparisons
ISBN:
Category : Medical
Languages : en
Pages : 1762
Book Description
This compact, portable, alphabetically organised drug reference provides quick access to current, reliable information on more than 4,500 commonly prescribed medications.Each drug monograph is divided into pharmacological and patient care considerations, and includes action, indications, contraindications, route/dosage, interactions, lab test interferences, adverse reactions, precautions/warnings, administration/storage, assessment/interventions, and patient/family education.Icons and a second colour are used to help readers quickly locate the information they are looking for. A colour identification section enables readers to identify drugs by appearance. Coverage includes the newest (US)FDA approvals, investigational and orphan drugs, and indications for labelled, unlabelled, and orphan uses.
Publisher: Facts and Comparisons
ISBN:
Category : Medical
Languages : en
Pages : 1762
Book Description
This compact, portable, alphabetically organised drug reference provides quick access to current, reliable information on more than 4,500 commonly prescribed medications.Each drug monograph is divided into pharmacological and patient care considerations, and includes action, indications, contraindications, route/dosage, interactions, lab test interferences, adverse reactions, precautions/warnings, administration/storage, assessment/interventions, and patient/family education.Icons and a second colour are used to help readers quickly locate the information they are looking for. A colour identification section enables readers to identify drugs by appearance. Coverage includes the newest (US)FDA approvals, investigational and orphan drugs, and indications for labelled, unlabelled, and orphan uses.
Remington
Author: Adeboye Adejare
Publisher: Academic Press
ISBN: 0128223898
Category : Science
Languages : en
Pages : 1032
Book Description
The PCP's Bicentennial Edition Remington: The Science and Practice of Pharmacy, Twenty Third Edition, offers a trusted, completely updated source of information for education, training, and development of pharmacists. Published for the first time with Elsevier, this edition includes coverage of biologics and biosimilars as uses of those therapeutics have increased substantially since the previous edition. Also discussed are formulations, drug delivery (including prodrugs, salts, polymorphism. With clear, detailed color illustrations, fundamental information on a range of pharmaceutical science areas, and information on new developments in industry, pharmaceutical industry scientists, especially those involved in drug discovery and development will find this edition of Remington an essential reference. Intellectual property professionals will also find this reference helpful to cite in patents and resulting litigations. Additional graduate and postgraduate students in Pharmacy and Pharmaceutical Sciences will refer to this book in courses dealing with medicinal chemistry and pharmaceutics. - Contains a comprehensive source of principles of drug discovery and development topics, especially for scientists that are new in the pharmaceutical industry such as those with trainings/degrees in chemistry and engineering - Provides a detailed source for formulation scientists and compounding pharmacists, from produg to excipient issues - Updates this excellent source with the latest information to verify facts and refresh on basics for professionals in the broadly defined pharmaceutical industry
Publisher: Academic Press
ISBN: 0128223898
Category : Science
Languages : en
Pages : 1032
Book Description
The PCP's Bicentennial Edition Remington: The Science and Practice of Pharmacy, Twenty Third Edition, offers a trusted, completely updated source of information for education, training, and development of pharmacists. Published for the first time with Elsevier, this edition includes coverage of biologics and biosimilars as uses of those therapeutics have increased substantially since the previous edition. Also discussed are formulations, drug delivery (including prodrugs, salts, polymorphism. With clear, detailed color illustrations, fundamental information on a range of pharmaceutical science areas, and information on new developments in industry, pharmaceutical industry scientists, especially those involved in drug discovery and development will find this edition of Remington an essential reference. Intellectual property professionals will also find this reference helpful to cite in patents and resulting litigations. Additional graduate and postgraduate students in Pharmacy and Pharmaceutical Sciences will refer to this book in courses dealing with medicinal chemistry and pharmaceutics. - Contains a comprehensive source of principles of drug discovery and development topics, especially for scientists that are new in the pharmaceutical industry such as those with trainings/degrees in chemistry and engineering - Provides a detailed source for formulation scientists and compounding pharmacists, from produg to excipient issues - Updates this excellent source with the latest information to verify facts and refresh on basics for professionals in the broadly defined pharmaceutical industry
Drug Interaction Facts
Author:
Publisher:
ISBN:
Category : Drug interactions
Languages : en
Pages : 1940
Book Description
Publisher:
ISBN:
Category : Drug interactions
Languages : en
Pages : 1940
Book Description
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Drug Information Handbook
Author: Charles F. Lacy
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 1836
Book Description
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 1836
Book Description
Drug Facts and Comparisons
Author:
Publisher:
ISBN: 9780932686893
Category :
Languages : en
Pages : 2397
Book Description
Publisher:
ISBN: 9780932686893
Category :
Languages : en
Pages : 2397
Book Description
The Review of Natural Products
Author: Ara DerMarderosian
Publisher:
ISBN: 9781574392258
Category : Materia medica
Languages : en
Pages : 0
Book Description
The Review of Natural Products is the foremost source of current natural product information for health care professionals. More than 300 in-depth monographs are included, based on scientific research, not just anecdotal information. The Review of Natural Products provides detailed information about natural products, including their botany, history, chemistry, pharmacology, medicinal uses, toxicology, and patient information. It also includes significantly documented drug interactions.
Publisher:
ISBN: 9781574392258
Category : Materia medica
Languages : en
Pages : 0
Book Description
The Review of Natural Products is the foremost source of current natural product information for health care professionals. More than 300 in-depth monographs are included, based on scientific research, not just anecdotal information. The Review of Natural Products provides detailed information about natural products, including their botany, history, chemistry, pharmacology, medicinal uses, toxicology, and patient information. It also includes significantly documented drug interactions.
Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309672104
Category : Medical
Languages : en
Pages : 427
Book Description
Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.
Publisher: National Academies Press
ISBN: 0309672104
Category : Medical
Languages : en
Pages : 427
Book Description
Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.